Teva

  • Teva shares plunge gain after weak third-quarter earnings

    By MAX SCHINDLER

  • Teva accuses Lilly in US court of infringing migraine drug patents

    By REUTERS

  • In a blow to Teva, US approves competitor's drug

    By MAX SCHINDLER

  • Yaron Neudorfer

    Yaron Neudorfer, CEO of Social Finance Israel, pays for success

    By SHLOMO MAITAL

  • New CEO to head struggling Teva Pharmaceuticals

    By MAX SCHINDLER

  • Teva reduces projected layoffs

    By MAX SCHINDLER

  • Teva

    Israel's Teva Pharmaceutical stocks drop nearly 18%

    By GLOBES

  • Teva

    Teva to undergo global rebrand

    By NIV ELIS

  • Teva

    Teva buys Mexican pharmaceutical company Rimsa for $2.3 billion

    By GLOBES

  • Teva

    In Israel's largest acquisition, Teva buys Allergan Generics for $40.5b

    By NIV ELIS,REUTERS

  • Cookie Settings